Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention.
ST-elevation myocardial infarction
infarct-related artery
microvascular obstruction
no reflow
percutaneous coronary intervention
Journal
Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
28
05
2023
revised:
12
07
2023
accepted:
01
08
2023
medline:
30
7
2024
pubmed:
30
7
2024
entrez:
30
7
2024
Statut:
epublish
Résumé
Primary percutaneous coronary intervention (PCI) is the current class I therapeutic approach to treat acute ST-elevation myocardial infarction (STEMI). While primary PCI can restore adequate flow in the infarcted artery in the majority of cases, some patients experience the 'no-reflow' phenomenon, i.e., an abnormal myocardial reperfusion occurring even after the occluded coronary artery has been opened. No-reflow occurs when microvascular obstruction arises from embolization of thrombus or components of the atheromatous plaques. These embolic materials travel downstream within the infarct-related artery at time of primary PCI, leading to compromised blood flow. Currently, no expert consensus documents exist to outline an optimal strategy to prevent or treat no-reflow. Interventional cardiologists frequently employ intracoronary adenosine, calcium channel blockers, nicorandil, nitroprusside or glycoprotein IIb/IIIa inhibitors. However, evidence suggests that these interventions consistently enhance myocardial blood flow in only a specific subset of patients experiencing no-reflow. A recent and innovative therapeutic approach gaining attention is low-dose fibrinolysis during primary PCI, which offers the potential to augment coronary flow post-myocardial revascularization.
Identifiants
pubmed: 39077094
doi: 10.31083/j.rcm2412365
pii: S1530-6550(23)01100-6
pmc: PMC11272854
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
365Informations de copyright
Copyright: © 2023 The Author(s). Published by IMR Press.
Déclaration de conflit d'intérêts
The author declares no conflict of interest. Francesco Pelliccia and Salvatore De Rosa are serving as one of the Editorial Board members and Guest editors of this journal. Marco Zimarino is serving as one of the Editorial Board members of this journal. Giuseppe Andò and Ciro Indolfi are serving as one of the Guest editors of this journal. We declare that Francesco Pelliccia, Marco Zimarino, Giuseppe Andò, Salvatore De Rosa and Ciro Indolfi had no involvement in the peer review of this article and have no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Giuseppe Boriani.